ACRS
NASDAQ · Pharmaceuticals
Aclaris Therapeutics Inc
$4.41
+0.07 (+1.61%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+303.4% upside
Low Target
$13.99
Average Target
$17.79
High Target
$22.90
Current Price
$4.41
Current
$4.41
$4.41
Target
$17.79
$17.79
$13.99
$17.79 avg
$22.90
Scenario Analysis
Bear Case
$13.99
217.2%
Low target
Base Case
$17.79
+303.4%
Avg target
Bull Case
$22.90
+419.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.89
-9.8% from high
52-Week Low
$1.16
+280.2% from low
Target vs 52W High
$17.79
+263.8% vs high
Next Earnings Report
May 12, 2026
1d
tomorrow
EPS Est: $-0.16
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals